Authors: SOLENTHALER BM SIGNER C SPEITH P ANDRESEN I

Citation: Bm. Solenthaler et al., BIOCOMPATIBILITY AND CLINICAL SAFETY OF METHYLENE BLUE LIGHT VIRUS-INACTIVATED AND LEUKOVIRTM-MB-FILTERED FRESH-FROZEN PLASMA/, Transfusion, 38(10), 1998, pp. 238-238

Authors: TRANKLE C ANDRESEN I LAMBRECHT G MOHR K

Citation: C. Trankle et al., M-2 RECEPTOR-BINDING OF THE SELECTIVE ANTAGONIST AF-DX-384 - POSSIBLEINVOLVEMENT OF THE COMMON ALLOSTERIC SITE, Molecular pharmacology, 53(2), 1998, pp. 304-312

Authors: TRANKLE C ANDRESEN I MOHR K

Citation: C. Trankle et al., EVIDENCE FOR AN INVOLVEMENT OF THE ALLOSTERIC SITE OF MUSCARINIC M-2 RECEPTORS IN THE BINDING OF THE M-2 SELECTIVE ANTAGONIST AF-DX-384, Naunyn-Schmiedeberg's archives of pharmacology, 356(4), 1997, pp. 189-189

Authors: HORAK FF JAGER S NIRNBERGER G BERGER U ANDRESEN I VIX JM REHN D

Citation: Ff. Horak et al., DOSE-RELATED CONTROL OF ALLERGIC RHINITIS SYMPTOMS BY A H1-RECEPTOR ANTAGONIST - FINDING THE PROPER DOSIS OF DIMETHINDENE MALEATE IN PATIENTS WITH ALLERGIC RHINITIS, International archives of allergy and immunology, 103(3), 1994, pp. 298-302

Authors: HORAK F JAGER S NIRNBERGER G BERGER U ANDRESEN I VIX JM REHN D

Citation: F. Horak et al., PHARMACODYNAMIC DOSE-FINDING OF DIMETINDENE IN A SUSTAINED-RELEASE FORMULATION, Arzneimittel-Forschung, 43-2(11), 1993, pp. 1193-1195